Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Change in Accured Expenses (2018 - 2026)

Arcturus Therapeutics Holdings filings provide 8 years of Change in Accured Expenses readings, the most recent being $4.5 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 32.09% to $4.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$15.3 million, a 357.33% decrease, with the full-year FY2025 number at -$15.3 million, down 357.33% from a year prior.
  • Change in Accured Expenses hit $4.5 million in Q4 2025 for Arcturus Therapeutics Holdings, up from -$5.4 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $10.6 million in Q2 2021 to a low of -$9.4 million in Q4 2021.
  • Median Change in Accured Expenses over the past 5 years was -$81000.0 (2023), compared with a mean of $182800.0.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 465.08% in 2021 and later crashed 2174.66% in 2025.
  • Arcturus Therapeutics Holdings' Change in Accured Expenses stood at -$9.4 million in 2021, then skyrocketed by 178.73% to $7.4 million in 2022, then tumbled by 61.65% to $2.8 million in 2023, then surged by 130.15% to $6.6 million in 2024, then tumbled by 32.09% to $4.5 million in 2025.
  • The last three reported values for Change in Accured Expenses were $4.5 million (Q4 2025), -$5.4 million (Q3 2025), and -$6.1 million (Q2 2025) per Business Quant data.